Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic Cancer
Study Details
Study Description
Brief Summary
The primary outcome is the change in lower extremity edema-related symptoms. Secondary outcomes include the compliance rate of management guidelines for lower extremity edema, the performance rate for pelvic and lower extremity exercise.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Pelvic and lower extremity exercise Experimental arm will be educated the guidelines for prevention and early detection of lower extremity edema. Additionally, pelvic and lower extremity exercise will be educated and participants will continue exercise for 1 year at home. |
Other: Pelvic and lower extremity exercise
|
No Intervention: Control Control group will be educated the guidelines for prevention and early detection of lower extremity edema |
Outcome Measures
Primary Outcome Measures
- Change in lower extremity edema-related symptoms after pelvic and lower extremities exercise [1 year after randomization]
Secondary Outcome Measures
- the compliance rate of management guidelines for lower extremity edema, the performance rate for pelvic and lower extremity exercise [1 year after randomization]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
More than 18 years of age
-
Patients who underwent pelvic lymphadenectomy
-
Patients with suspicious pelvic cancer who finished active treatments such as chemotherapy, radiotherapy or surgery. The interval between the time of randomization and the end of the treatment should be more than 2 weeks.
-
The patient is able to understand the study and is willing to give written informed consent to the study
-
patient with edema-related symptoms such as leg heaviness, distension, tightness, pain, limited movement, or weakness etc.
Exclusion Criteria:
-
Severe systemic diseases causing peripheral edema, including renal disease
-
Severe or uncontrolled cardiopulmonary disease, including implantable device such as a pacemaker
-
Acute superficial or deep vein thrombosis
-
Previous major surgery for lower extremities, including metallic surgical implant
-
Local infection in the lower extremities
-
Auto-immunological disorders or vasculitis
-
Use of systemic corticosteroids
-
Pregnant or currently breastfeeding
-
Alcohol or drug abuse
-
Uncontrolled diabetes
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Myong Cheol Lim | Goyang-si | Gyeonggi-do | Korea, Republic of | 410-769 |
Sponsors and Collaborators
- National Cancer Center, Korea
Investigators
- Principal Investigator: Lim Myong Cheol, MD,PhD, National Cancer Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NCCNCS-13-723